The results of the Heartmate II DT trial will be available at the AHA ... be reduced or significantly improved with a period of VAD support. Of patients implanted with the Heartmate XVE device ...
The HeartMate II is currently the only continuous-flow left-ventricular assist device (LVAD) approved by the FDA for both bridge-to-transplantation and destination therapy. Because of its ...
A key indicator of finding a soulmate is a deep level of communication characterized by effortless understanding, open ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback